VistaGen Therapeutics
VTGN
VTGN
116 hedge funds and large institutions have $168M invested in VistaGen Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 9 closing their positions.
Holders
116
Holders Change
+10
Holders Change %
+9.43%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
30
Reduced
39
Closed
9
Calls
$41K
Puts
$487K
Net Calls
-$446K
Net Calls Change
+$520K
Top Buyers
1 |
CC
1
Commodore Capital
New York
|
$12.5M |
2 |
2
Norges Bank
Oslo,
Norway
|
$1.64M |
3 |
3
Millennium Management
New York
|
$1.54M |
4 |
4
Renaissance Technologies
New York
|
$1.46M |
5 |
SFM
5
Sphera Funds Management
Tel Aviv,
Israel
|
$6.14M |